Empirical Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Empirical Asset Management's PFE Position: Q2 2026 in Review
Empirical Asset Management increased its Pfizer (PFE) stake by 47% in Q2 2026, buying an estimated $110K and bringing the position to 13,097 shares worth $315K. The position accounts for 0.07% of the portfolio, ranked #301.
Empirical Asset Management first reported a position in PFE in Q3 2022 and has held it in 11 quarters since. The position peaked at $351K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Empirical Asset Management held 13,097 shares of Pfizer worth $315K as of Q2 2026.
- Empirical Asset Management bought 4,189 Pfizer shares in Q2 2026, an estimated $110K.
- Pfizer made up 0.07% of Empirical Asset Management's portfolio in Q2 2026, its #301 holding.
- Empirical Asset Management first reported a position in Pfizer in Q3 2022 and has held it in 11 quarters since.
- Empirical Asset Management's Pfizer position peaked at $351K in Q4 2024.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.